Prognostic effect of cachexia in patients with non‐small cell lung cancer receiving immune checkpoint inhibitors

Abstract

In NSCLC patients, cachexia was associated with a worse prognosis, irrespective of tumor PD-L1 expression, indicating that cachexia is a predictive factor for NSCLC patients receiving immune checkpoint inhibitors.